{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:17:56Z","timestamp":1773800276021,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T00:00:00Z","timestamp":1561420800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T00:00:00Z","timestamp":1561420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol. Sin."],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s12250-019-00138-9","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T14:03:13Z","timestamp":1561471393000},"page":"583-591","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7360-2913","authenticated-orcid":false,"given":"Wenling","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baoying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjie","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6656-5934","authenticated-orcid":false,"given":"Li","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","published-online":{"date-parts":[[2019,6,25]]},"reference":[{"key":"138_CR1","doi-asserted-by":"publisher","first-page":"4460","DOI":"10.1016\/j.vaccine.2011.04.040","volume":"29","author":"J Adler-moore","year":"2011","unstructured":"Adler-moore J, Munoz M, Kim H, Romero J, Tumpey T, Zeng H, Petro C, Ernst W, Kosina S, Jimenez G, Fujii G (2011) Characterization of the murine Th2 response to immunization with liposomal M2e influenza vaccine. Vaccine 29:4460\u20134468","journal-title":"Vaccine"},{"key":"138_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/cei.13004","volume":"190","author":"AF Altenburg","year":"2017","unstructured":"Altenburg AF, Magnusson SE, Bosman F, Stertman L, De Vries R, Rimmelzwaan GF (2017) Protein- and modified vaccinia virus Ankara-based influenza virus nucleoprotein vaccines are differentially immunogenic in BALB\/c mice. Clin Exp Immunol 190:19\u201328","journal-title":"Clin Exp Immunol"},{"key":"138_CR3","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.vaccine.2012.11.072","volume":"31","author":"P Alvarez","year":"2013","unstructured":"Alvarez P, Zylberman V, Ghersi G, Boado L, Palacios C, Goldbaum F, Mattion N (2013) Tandem repeats of the extracellular domain of matrix 2 influenza protein exposed in Brucella lumazine synthase decameric carrier molecule induce protection in mice. Vaccine 31:806\u2013812","journal-title":"Vaccine"},{"key":"138_CR4","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.1016\/j.vaccine.2018.05.061","volume":"36","author":"X Chuai","year":"2018","unstructured":"Chuai X, Xie B, Chen H, Tan X, Wang W, Huang B, Deng Y, Li W, Tan W (2018) The immune response of rhesus macaques to novel vaccines comprising hepatitis B virus S, PreS1, and Core antigens. Vaccine 36:3740\u20133746","journal-title":"Vaccine"},{"key":"138_CR5","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ebiom.2018.02.011","volume":"29","author":"L Coughlan","year":"2018","unstructured":"Coughlan L, Sridhar S, Payne R, Edmans M, Milicic A, Venkatraman N, Lugonja B, Clifton L, Qi C, Folegatti PM, Lawrie AM, Roberts R, de Graaf H, Sukhtankar P, Faust SN, Lewis DJM, Lambe T, Hill AVS, Gilbert SC (2018) Heterologous two-dose vaccination with simian adenovirus and poxvirus vectors elicits long-lasting cellular immunity to influenza virus A in healthy adults. EBioMedicine 29:146\u2013154","journal-title":"EBioMedicine"},{"key":"138_CR6","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1128\/JVI.02705-15","volume":"90","author":"R Dhanwani","year":"2016","unstructured":"Dhanwani R, Zhou Y, Huang Q, Verma V, Dileepan M, Ly H, Liang Y (2016) A novel live Pichinde virus-based vaccine vector induces enhanced humoral and cellular immunity after a booster dose. J Virol 90:2551\u20132560","journal-title":"J Virol"},{"key":"138_CR7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1080\/20477724.2016.1275465","volume":"111","author":"G Di Mario","year":"2017","unstructured":"Di Mario G, Sciaraffia E, Facchini M, Gubinelli F, Soprana E, Panigada M, Bernasconi V, Garulli B, Siccardi A, Donatelli I, Castrucci MR (2017) Protective immunity against influenza in HLA-A2 transgenic mice by modified vaccinia virus Ankara vectored vaccines containing internal influenza proteins. Pathog Glob Health 111:76\u201382","journal-title":"Pathog Glob Health"},{"key":"138_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.virol.2012.04.015","volume":"430","author":"SM Ebrahimi","year":"2012","unstructured":"Ebrahimi SM, Dabaghian M, Tebianian M, Zabeh Jazi MH (2012) In contrast to conventional inactivated influenza vaccines, 4\u2009\u00d7\u2009M2e.HSP70c fusion protein fully protected mice against lethal dose of H1, H3 and H9 influenza A isolates circulating in Iran. Virology 430:63\u201372","journal-title":"Virology"},{"key":"138_CR9","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1126\/science.1125347","volume":"312","author":"EJ Emanuel","year":"2006","unstructured":"Emanuel EJ, Wertheimer A (2006) Who should get influenza vaccine when not all can. Science 312:854\u2013855","journal-title":"Science"},{"key":"138_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/infdis\/jiy103","volume":"218","author":"EJ Erbelding","year":"2018","unstructured":"Erbelding EJ, Post DJ, Stemmy EJ, Roberts PC, Augustine AD, Ferguson S, Paules CI, Graham BS, Fauci AS (2018) A universal influenza vaccine: the strategic plan for the national institute of allergy and infectious diseases. J Infect Dis 218:347\u2013354","journal-title":"J Infect Dis"},{"key":"138_CR100","volume-title":"Smallpox and its eradication","author":"F Fenner","year":"1988","unstructured":"Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID (1988) Smallpox and its eradication. World Health Organization, Geneva"},{"key":"138_CR11","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1099\/jgv.0.000518","volume":"97","author":"Y Fujimoto","year":"2016","unstructured":"Fujimoto Y, Tomioka Y, Takakuwa H, Uechi GI, Yabuta T, Ozaki K, Suyama H, Yamamoto S, Morimatsu M, Mai LQ (2016) Cross-protective potential of anti-nucleoprotein human monoclonal antibodies against lethal influenza A virus infection. J Gen Virol 97:2104\u20132116","journal-title":"J Gen Virol"},{"key":"138_CR12","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00705-010-0756-3","volume":"155","author":"L Guo","year":"2010","unstructured":"Guo L, Zheng M, Ding Y, Li D, Yang Z, Wang H, Chen Q, Sui Z, Fang F, Chen Z (2010) Protection against multiple influenza A virus subtypes by intranasal administration of recombinant nucleoprotein. Arch Virol 155:1765\u20131775","journal-title":"Arch Virol"},{"key":"138_CR13","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1164\/rccm.201411-1988OC","volume":"191","author":"AC Hayward","year":"2015","unstructured":"Hayward AC, Wang L, Goonetilleke N, Fragaszy EB, Bermingham A, Copas A, Dukes O, Millett ERC, Nazareth I, Nguyen-Van-Tam JS, Watson JM, Zambon M, Johnson AM, McMichael AJ (2015) Natural T cell-mediated protection against seasonal and pandemic influenza: results of the flu watch cohort study. Am J Respir Crit Care Med 191:1422\u20131431","journal-title":"Am J Respir Crit Care Med"},{"key":"138_CR14","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/1743-422X-9-322","volume":"9","author":"B Huang","year":"2012","unstructured":"Huang B, Wang W, Li R, Wang X, Jiang T, Qi X, Gao Y, Tan W, Ruan L (2012) Influenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in mice. Virol J 9:322","journal-title":"Virol J"},{"key":"138_CR15","first-page":"818","volume":"215","author":"S Jegaskanda","year":"2017","unstructured":"Jegaskanda S, Co MDT, Cruz J, Subbarao K, Ennis FA, Terajima M (2017) Induction of H7N9-cross-reactive antibody-dependent cellular cytotoxicity antibodies by human seasonal influenza a viruses that are directed toward the nucleoprotein. J Infect Dis 215:818\u2013823","journal-title":"J Infect Dis"},{"key":"138_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/annotation\/c8b2e360-b78a-4c2f-a1a3-c53325f18211","volume":"8","author":"SH Kim","year":"2013","unstructured":"Kim SH, Kim JY, Choi Y, Nguyen HH, Song MK, Chang J (2013) Mucosal vaccination with recombinant adenovirus encoding nucleoprotein provides potent protection against influenza virus infection. PLoS ONE 8:1\u201311","journal-title":"PLoS ONE"},{"key":"138_CR17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.bbrc.2017.09.011","volume":"493","author":"YJ Kim","year":"2017","unstructured":"Kim YJ, Ko EJ, Kim MC, Lee YN, Kim KH, Jung YJ, Kang SM (2017) Roles of antibodies to influenza A virus hemagglutinin, neuraminidase, and M2e in conferring cross protection. Biochem Biophys Res Commun 493:393\u2013398","journal-title":"Biochem Biophys Res Commun"},{"key":"138_CR18","doi-asserted-by":"publisher","first-page":"e0189780","DOI":"10.1371\/journal.pone.0189780","volume":"12","author":"MT Koday","year":"2017","unstructured":"Koday MT, Leonard JA, Munson P, Forero A, Koday M, Bratt DL, Fuller JT, Murnane RD, Qin S, Reinhart TA, Duus K, Messaoudi I, Hartman AL, Stefano-Cole K, Morrison J, Katze MG, Fuller DH (2017) Multigenic DNA vaccine induces protective cross-reactive T cell responses against heterologous influenza virus in nonhuman primates. PLoS One 12:e0189780","journal-title":"PLoS One"},{"key":"138_CR38","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1080\/21645515.2015.1016674","volume":"11","author":"X Kui","year":"2015","unstructured":"Kui X, Guan Y, Zhou Y, Yan SS, Zhang L, Li HJ, Sun MS (2015) Progress on adenovirus-vectored universal influenza vaccines. Hum Vaccines Immunother 11:1209\u20131222","journal-title":"Hum Vaccines Immunother"},{"key":"138_CR19","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.4049\/jimmunol.1003057","volume":"186","author":"MW Lamere","year":"2011","unstructured":"LaMere MW, Lam HT, Moquin A, Haynes L, Lund FE, Randall TD, Kaminski DA (2011) Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus. J Immunol 186:4331\u20134339","journal-title":"J Immunol"},{"key":"138_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4110\/in.2015.15.5.213","volume":"15","author":"YN Lee","year":"2015","unstructured":"Lee YN, Kim MC, Lee YT, Kim YJ, Kang SM (2015) Mechanisms of cross-protection by influenza virus M2-based vaccines. Immune Netw 15:213\u2013221","journal-title":"Immune Netw"},{"key":"138_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12934-015-0287-4","volume":"14","author":"H Lei","year":"2015","unstructured":"Lei H, Peng X, Jiao H, Zhao D, Ouyang J (2015) Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice. Microb Cell Fact 14:111","journal-title":"Microb Cell Fact"},{"key":"138_CR22","doi-asserted-by":"publisher","first-page":"5985","DOI":"10.1128\/JVI.00120-13","volume":"87","author":"Z Li","year":"2013","unstructured":"Li Z, Gabbard JD, Mooney AJ, Gao X, Chen Z, Place RJ, Tompkins SM, He B (2013) Single-dose vaccination of a recombinant parainfluenza virus 5 expressing NP from H5N1 virus provides broad immunity against influenza A viruses. J Virol 87:5985\u20135993","journal-title":"J Virol"},{"key":"138_CR23","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/1743-422X-10-227","volume":"10","author":"J Ma","year":"2013","unstructured":"Ma J, Yang F, Yu H, Zhou Y, Li G, Huang M, Wen F, Tong G (2013) An M2e-based synthetic peptide vaccine for influenza A virus confers heterosubtypic protection from lethal virus challenge. Virol J 10:227","journal-title":"Virol J"},{"key":"138_CR24","doi-asserted-by":"publisher","first-page":"e61775","DOI":"10.1371\/journal.pone.0061775","volume":"8","author":"MK MacLeod","year":"2013","unstructured":"MacLeod MK, David A, Jin N, Noges L, Wang J, Kappler JW, Marrack P (2013) Influenza nucleoprotein delivered with aluminium salts protects mice from an influenza A virus that expresses an altered nucleoprotein sequence. PLoS One 8:e61775","journal-title":"PLoS One"},{"key":"138_CR25","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.vaccine.2016.02.028","volume":"34","author":"J Mullin","year":"2016","unstructured":"Mullin J, Ahmed MS, Sharma R, Upile N, Beer H, Achar P, Puksuriwong S, Ferrara F, Temperton N, McNamara P, Lambe T, Gilbert SC, Zhang Q (2016) Activation of cross-reactive mucosal T and B cell responses in human nasopharynx-associated lymphoid tissue in vitro by modified vaccinia Ankara-vectored influenza vaccines. Vaccine 34:1688\u20131695","journal-title":"Vaccine"},{"key":"138_CR26","doi-asserted-by":"publisher","first-page":"813047","DOI":"10.1155\/2015\/813047","volume":"2015","author":"JE Mu\u00f1oz-Medina","year":"2015","unstructured":"Mu\u00f1oz-Medina JE, S\u00e1nchez-Vallejo CJ, M\u00e9ndez-Tenorio A, Monroy-Mu\u00f1oz IE, Angeles-Mart\u00ednez J, Santos Coy-Arechavaleta A, Santacruz-Tinoco CE, Gonz\u00e1lez-Ibarra J, Anguiano-Hern\u00e1ndez YM, Gonz\u00e1lez-Bonilla CR, Ram\u00f3n-Gallegos E, D\u00edaz-Qui\u00f1onez JA (2015) In silico identification of highly conserved epitopes of influenza A H1N1, H2N2, H3N2, and H5N1 with diagnostic and vaccination potential. Biomed Res Int 2015:813047","journal-title":"Biomed Res Int"},{"key":"138_CR27","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s00299-015-1758-0","volume":"34","author":"HN Nahampun","year":"2015","unstructured":"Nahampun HN, Bosworth BT, Cunnick JE, Mogler M, Wang K (2015) Expression of H3N2 nucleoprotein in maize seeds and immunogenicity in mice. Plant Cell Rep 34:969\u2013980","journal-title":"Plant Cell Rep"},{"key":"138_CR28","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.4049\/jimmunol.180.3.1758","volume":"180","author":"M Roti","year":"2008","unstructured":"Roti M, Yang J, Berger D, Huston L, James EA, Kwok WW (2008) Healthy human subjects have CD4+ T cells directed against H5N1 influenza virus. J Immunol 180:1758\u20131768","journal-title":"J Immunol"},{"key":"138_CR29","first-page":"2","volume":"8","author":"L Ruan","year":"2013","unstructured":"Ruan L (2013) Research and application of vaccinia virus Tiantan strain vector. J Microbes Infect 8:2\u20138 (in Chinese)","journal-title":"J Microbes Infect"},{"key":"138_CR30","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1586\/erv.09.6","volume":"8","author":"M Schotsaert","year":"2009","unstructured":"Schotsaert M, De Filette M, Fiers W, Saelens X (2009) Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments. Expert Rev Vaccines 8:499\u2013508","journal-title":"Expert Rev Vaccines"},{"key":"138_CR31","doi-asserted-by":"publisher","first-page":"e0191574","DOI":"10.1371\/journal.pone.0191574","volume":"13","author":"I Tutykhina","year":"2018","unstructured":"Tutykhina I, Esmagambetov I, Bagaev A, Pichugin A, Lysenko A, Shcherbinin D, Sedova E, Logunov D, Shmarov M, Ataullakhanov R, Naroditsky B, Gintsburg A (2018) Vaccination potential of B and T epitope-enriched NP and M2 against influenza A viruses from different clades and hosts. PLoS One 13:e0191574","journal-title":"PLoS One"},{"key":"138_CR32","first-page":"377","volume":"23","author":"W Wang","year":"2007","unstructured":"Wang W, Huang B, Deng Y, Wang X, Tan W, Ruan L (2007) Expression of influenza A3 virus (H3N2) M2 gene in vaccinia virus Tiantan strain. Chin J Virol 23:377","journal-title":"Chin J Virol"},{"key":"138_CR33","doi-asserted-by":"publisher","first-page":"e52488","DOI":"10.1371\/journal.pone.0052488","volume":"7","author":"W Wang","year":"2012","unstructured":"Wang W, Huang B, Jiang T, Wang X, Qi X, Gao Y, Tan W, Ruan L (2012) Robust immunity and heterologous protection against influenza in mice elicited by a novel recombinant NP-M2e fusion protein expressed in E. coli. PLoS One 7:e52488","journal-title":"PLoS One"},{"key":"138_CR34","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.virol.2014.08.008","volume":"468","author":"W Wang","year":"2014","unstructured":"Wang W, Huang B, Jiang T, Wang X, Qi X, Tan W, Ruan L (2014) Maximal immune response and cross protection by influenza virus nucleoprotein derived from E. coli using an optimized formulation. Virology 468:265\u2013273","journal-title":"Virology"},{"key":"138_CR35","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1128\/CVI.00091-15","volume":"22","author":"W Wang","year":"2015","unstructured":"Wang W, Li R, Deng Y, Lu N, Chen H, Meng X, Wang W, Wang X, Yan K, Qi X, Zhang X, Xin W, Lu Z, Li X, Bian T, Gao Y, Tan W, Ruan L (2015) Protective efficacy of the conserved NP, PB1, and M1 proteins as immunogens in DNA- and vaccinia virus-based universal influenza A virus vaccines in mice. Clin Vaccine Immunol 22:618\u2013630","journal-title":"Clin Vaccine Immunol"},{"key":"138_CR36","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1038\/mt.2013.122","volume":"21","author":"B Wen","year":"2013","unstructured":"Wen B, Deng Y, Chen H, Guan J, Chuai X, Ruan L, Kong W, Tan W (2013) the novel replication-defective vaccinia virus (Tiantan strain)-based hepatitis C virus vaccine induces robust immunity in macaques. Mol Ther 21:1787\u20131795","journal-title":"Mol Ther"},{"key":"138_CR37","unstructured":"World Health Organization (WHO) (2019) Influenza (seasonal) fact sheet. \n                    https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/influenza-(seasonal)\n                    \n                  . Accessed 1 Feb 2019"},{"key":"138_CR39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1089\/vim.2008.0064","volume":"22","author":"K Yan","year":"2009","unstructured":"Yan K, Tan W, Wang H, Wang Y, Zhang X, Li Y, Ruan L (2009) SARS-CoV spike proteins expressed by the vaccinia virus Tiantan strain: secreted SQ protein induces robust neutralization antibody in mice. Viral Immunol 22:57\u201366","journal-title":"Viral Immunol"},{"key":"138_CR40","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1128\/JVI.62.8.2762-2772.1988","volume":"62","author":"SL Zebedee","year":"1988","unstructured":"Zebedee SL, Lamb RA (1988) Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. J Virol 62:2762\u20132772","journal-title":"J Virol"},{"key":"138_CR41","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1159\/000319440","volume":"54","author":"X Zhang","year":"2011","unstructured":"Zhang X, Liu M, Liu C, Du J, Shi W, Sun E, Li H, Li J, Zhang Y (2011) Vaccination with different M2e epitope densities confers partial protection against H5N1 influenza A virus challenge in chickens. Intervirology 54:290\u2013299","journal-title":"Intervirology"},{"key":"138_CR42","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.micinf.2014.12.006","volume":"17","author":"N Zhang","year":"2015","unstructured":"Zhang N, Zheng B-J, Lu L, Zhou Y, Jiang S, Du L (2015) Advancements in the development of subunit influenza vaccines. Microbes Infect 17:123\u2013134","journal-title":"Microbes Infect"},{"key":"138_CR43","doi-asserted-by":"publisher","first-page":"7233","DOI":"10.1016\/j.vaccine.2010.08.049","volume":"28","author":"G Zhao","year":"2010","unstructured":"Zhao G, Du L, Xiao W, Sun S, Lin Y, Chen M, Kou Z, He Y, Lustigman S, Jiang S, Zheng B-J, Zhou Y (2010a) Induction of protection against divergent H5N1 influenza viruses using a recombinant fusion protein linking influenza M2e to Onchocerca volvulus activation associated protein-1 (ASP-1) adjuvant. Vaccine 28:7233\u20137240","journal-title":"Vaccine"},{"key":"138_CR44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/1743-422X-7-151","volume":"7","author":"G Zhao","year":"2010","unstructured":"Zhao G, Sun S, Du L, Xiao W, Ru Z, Kou Z, Guo Y, Yu H, Jiang S, Lone Y (2010b) An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus. Virol J 7:151","journal-title":"Virol J"},{"key":"138_CR45","doi-asserted-by":"publisher","first-page":"397","DOI":"10.4161\/21645515.2014.995056","volume":"11","author":"M Zheng","year":"2015","unstructured":"Zheng M, Liu F, Shen Y, Wang S, Xu W, Fang F, Sun B, Xie Z, Chen Z (2015) Cross-protection against influenza virus infection by intranasal administration of nucleoprotein-based vaccine with compound 48\/80 adjuvant. Hum Vaccines Immunother 11:397\u2013406","journal-title":"Hum Vaccines Immunother"},{"key":"138_CR46","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1016\/j.vaccine.2012.03.021","volume":"30","author":"C Zhou","year":"2012","unstructured":"Zhou C, Zhou L, Chen Y (2012) Immunization with high epitope density of M2e derived from 2009 pandemic H1N1 elicits protective immunity in mice. Vaccine 30:3463\u20133469","journal-title":"Vaccine"}],"container-title":["Virologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12250-019-00138-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12250-019-00138-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12250-019-00138-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T06:40:37Z","timestamp":1641278437000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12250-019-00138-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,25]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["138"],"URL":"https:\/\/doi.org\/10.1007\/s12250-019-00138-9","relation":{},"ISSN":["1674-0769","1995-820X"],"issn-type":[{"value":"1674-0769","type":"print"},{"value":"1995-820X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,25]]},"assertion":[{"value":"1 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The whole study was approved by the Administrative Committee on Animal Welfare of the National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (Laboratory Animal Care and Use Committee Authorization, permit number 2016022910). All institutional and national guidelines for the care and use of laboratory animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal and Human Rights Statement"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}